NATURAL-KILLER AND LYMPHOKINE ACTIVATED KILLER-CELL FUNCTIONS IN HODGKINS-DISEASE

被引:10
|
作者
RAJARAM, N
TATAKE, RJ
ADVANI, SH
GANGAL, SG
机构
[1] CANC RES INST,DIV IMMUNOL,BOMBAY 400012,INDIA
[2] TATE MEM HOSP,TATA MEM CTR,BOMBAY 400012,INDIA
关键词
D O I
10.1038/bjc.1990.261
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report the natural killer (NK) and lymphokine activated killer (LAK) cell activities in peripheral blood lymphocytes (PBL) from untreated patients with Hodgkin’s disease (HD) and from healthy donors. The frequency of LAK cell precursors was also studied using limiting dilution analysis (LDA). About 75% of the HD patients had normal NK activity. There was a higher percentage of low NK responders (mean percent NK activity of healthy donors - 2 SD) in patients with lymphocyte depletion histologic grade of the disease and those who were in clinical stage IV, suggesting a correlation of decrease in NK activity with poor prognosis. We found efficient LAK activity against the NK-sensitive K562 cells and NK-resistant VIP (melanoma) and T-24 (bladder carcinoma) tumour targets in both low and normal NK responder HD patients, irrespective of the histopathological grade and clinical stage of the disease. In concordance with their good LAK cell activity, HD patients showed a frequency distribution of LAK cell progenitors in the PBL comparable to that of healthy donors. © The MacMillan Press Ltd., 1990.
引用
收藏
页码:205 / 208
页数:4
相关论文
共 50 条
  • [21] LYMPHOKINE ACTIVATED KILLER-CELL PRODUCTION IN PATIENTS WITH GASTROINTESTINAL CANCER
    MONSON, JRT
    RAMSDEN, C
    GILES, GR
    BRENNAN, TG
    GUILLOU, PJ
    GUT, 1986, 27 (10) : 1257 - 1257
  • [22] INVIVO BOOSTING OF LUNG NATURAL-KILLER AND LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITY BY INTERLEUKIN-2 - COMPARISON OF SYSTEMIC, INTRAPLEURAL AND INHALATION ROUTES
    FLEXMAN, JP
    MANNING, LS
    ROBINSON, BWS
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1990, 82 (01): : 151 - 156
  • [23] LYMPHOKINE-ACTIVATED KILLER-CELL TRAFFIC IN METASTATIC MELANOMA
    DUMMER, R
    SCHAFER, E
    EILLES, C
    BORNER, W
    BURG, G
    LANCET, 1991, 338 (8764): : 456 - 457
  • [24] AUGMENTATION OF LYMPHOKINE-ACTIVATED KILLER-CELL ACTIVITY BY LENTINAN
    TANI, M
    TANIMURA, H
    YAMAUE, H
    TSUNODA, T
    IWAHASHI, M
    NOGUCHI, K
    TAMAI, M
    HOTTA, T
    MIZOBATA, S
    ANTICANCER RESEARCH, 1993, 13 (5C) : 1773 - 1776
  • [25] NATURAL-KILLER CELL OR NATURAL-KILLER ACTIVITY
    DEGOS, L
    M S-MEDECINE SCIENCES, 1989, : 18 - 19
  • [26] NATURAL-KILLER AND LYMPHOKINE ACTIVATED KILLER CELL-ACTIVITY IN PATIENTS WITH CUTANEOUS T-CELL LYMPHOMA (CTCL)
    JEGASOTHY, B
    THARP, M
    SHU, S
    MCCOY, P
    CHARLEY, M
    WHITESIDE, T
    CLINICAL RESEARCH, 1988, 36 (03): : A657 - A657
  • [27] NATURAL-KILLER AND LYMPHOKINE ACTIVATED KILLER CELL-ACTIVITY IN PATIENTS WITH CUTANEOUS T-CELL LYMPHOMA (CTCL)
    JEGASOTHY, B
    THARP, M
    SHU, S
    MCCOY, P
    CHARLEY, M
    WHITESIDE, T
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1988, 90 (04) : 571 - 571
  • [29] INVITRO NATURAL-KILLER AND LYMPHOKINE-ACTIVATED KILLER ACTIVITY IN PATIENTS WITH BRONCHOGENIC-CARCINOMA
    DUNLAP, NE
    LANE, VG
    CLOUD, GA
    TILDEN, AB
    CANCER, 1990, 66 (07) : 1499 - 1504
  • [30] NATURAL-KILLER ACTIVITY IN SPLEENS AND LYMPH-NODES FROM PATIENTS WITH HODGKINS-DISEASE
    RUCO, LP
    PROCOPIO, A
    UCCINI, S
    MARCORELLI, E
    BARONI, CD
    CANCER RESEARCH, 1982, 42 (05) : 2063 - 2068